Exelixis
Trade Exelixis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
With a market cap of 11.04B, Exelixis(EXEL) trades at $40.88. The stock has a price-to-earnings ratio of 17.21.
As of 2025-12-14, Exelixis(EXEL) stock has fluctuated between $40.66 and $42.00. The current price stands at $40.88, placing the stock +0.5% above today's low and -2.7% off the high.
Exelixis(EXEL) shares are trading with a volume of 2.57M, against a daily average of 2.69M.
During the past year, Exelixis(EXEL) stock moved between $31.90 at its lowest and $49.62 at its peak.
During the past year, Exelixis(EXEL) stock moved between $31.90 at its lowest and $49.62 at its peak.
EXEL News
Exelixis (EXEL) has quietly rewarded patient shareholders, with the stock up around 31% year to date and roughly 24% over the past year, outpacing many mid cap...
Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis on December 5 and set a price target of $45.00. TipRanks Cyber Monday Sale Claim 60% off...